LOS ANGELES--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company with products for the treatment of acute respiratory diseases, dermatological conditions, and xerostomia, announced today the launch of Xyralid™ Cream (lidocaine HCl 3%/hydrocortisone acetate 1%), a convenience kit that also contains Cleré™, a soap free cleanser. Xyralid™ Cream is the third product in the Xyralid™ franchise which also includes Xyralid™ RC (lidocaine HCl 3%/hydrocortisone acetate 1%) and Xyralid™ LP Lotion (lidocaine HCl 3%/hydrocortisone acetate 0.5%).
